REGENXBIO announces completion of phase I/IIA RGX-314 clinical trial

Every subject received one dose of RGX-314 managed by subretinal delivery. The leading clinical-stage biotechnology company REGENXBIO Inc. has recently announced that it has finished dosing across all 5 cohorts in the Phase I/IIa medical t....

Eve & Co confirms second German supply deal for sale of dried cannabis

It expects to begin shipments following the estimated Q2 2019 completion of its 780,000 square foot greenhouse extension Eve & Co has recently announced that Natural MedCo Ltd, its wholly owned subsidiary has entered into a second bind....

CA-based XStream Trucking bags $10.5 million in Series A funding

The investment will be used to enhance XStream’s ability to deliver better fuel-efficiency to the U.S. trucking industry by means of innovative hardware & software solutions. Renowned vehicle design & engineering company, XSt....

Treos Bio announces results from trial of precision cancer vaccine

Preliminary outcomes of the first part of the study have been made available and results of the second part are anticipated to be published in the third quarter of this year. The immuno-oncology company Treos Bio Ltd. has reportedly announ....

TaniGroup raises $10M in a funding round led by Openspace Ventures

TaniGroup runs an agriculture marketplace called TaniHub, and peer-to-peer lender named TaniFund. Indonesia-based TaniGroup has reportedly raised $10 million in Series A funding round which was led by Openspace Ventures in the latest deal....

Google to shut down the standalone YouTube Gaming App on May 30

The application was launched back in 2015 and was Google’s attempt to with the growing popularity of Twitch. The decision to shut down the standalone application comes as the company has already moved the app’s features to th....

Novartis grants milestone payment to Cadent for Phase 2 MIJ821 trial

MIJ821 is a potent and selective NMDA receptor modulator being developed for the treatment of treatment-resistant depression Cadent Therapeutics, a precision neuroscience company, has recently announced that it has received the second mile....

89bio reports positive data from Phase 1 clinical trial of BIO89-100

A clinical-stage biopharmaceutical company, 89bio LTD that focusses on NASH (nonalcoholic steatohepatitis), liver and other metabolic disorders, recently announced positive results from Phase 1 SAD (single ascending dose) study on healthy v....

UDG Healthcare acquires Incisive Health and Putnam Associates

Both acquisitions are good cultural & strategic fit and meet the company’s financial hurdle rates while further expanding its current capabilities. UDG would be financing both transactions from its existing cash & debt faci....

EU, China ink deals to reinforce partnership on civil aviation safety

The agreements will enable passengers to benefit from safer, economical, and greener air travel options The European Union (EU) has reportedly signed two agreements on civil aviation with China that are aimed at creating jobs, boost growth....